Kidney patients needed for diabetes drug dosing study
NCT ID NCT07385547
First seen Feb 04, 2026 · Last updated May 01, 2026 · Updated 11 times
Summary
This study looks at how different levels of kidney function affect the way the body handles a new long-acting diabetes drug called GL0034. About 40 adults with type 2 diabetes will receive one dose of the drug. Researchers will measure drug levels in the blood and check for side effects to help decide the right dose for people with kidney problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE II DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Orlando Clinical Research Center (OCRC)
NOT_YET_RECRUITINGOrlando, Florida, 32809, United States
-
Panax Clinical Research
RECRUITINGMiami Lakes, Florida, 33014, United States
-
Syneos Miami
NOT_YET_RECRUITINGMiami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.